HomeZVSA • NASDAQ
add
Zyversa Therapeutics Inc
Previous close
$0.52
Day range
$0.49 - $0.53
Year range
$0.47 - $6.30
Market cap
2.51M USD
Avg Volume
7.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.14M | -24.13% |
Net income | -2.26M | 20.16% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.14M | 24.12% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.61M | -20.75% |
Total assets | 20.99M | -3.07% |
Total liabilities | 12.86M | 23.28% |
Total equity | 8.13M | — |
Shares outstanding | 4.77M | — |
Price to book | 0.17 | — |
Return on assets | -25.79% | — |
Return on capital | -64.41% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.26M | 20.16% |
Cash from operations | -1.77M | 53.08% |
Cash from investing | — | — |
Cash from financing | 1.85M | -30.68% |
Net change in cash | 80.61K | 107.30% |
Free cash flow | -956.76K | 65.77% |
About
Founded
2014
Headquarters
Website
Employees
7
